You are here: Industry Insights > Covaxin

News List

Bharat Biotech gets $15 mn upfront from Ocugen for rights to commercialise Covaxin in Canada expresspharma
June 09, 2021
Ocugen has agreed to pay another $10 million to Bharat Biotech within a month from the commercial launch of Covaxin in Canada.
Anvisa allows import of Covaxin, Sputnik V into Brazil, but conditions apply expresspharma
June 07, 2021
According to Anvisa's approval, Brazil is expected to receive four million doses of Covaxin initially.
Ocugen, Bharat Biotech sign agreement for commercialisation rights to COVAXIN in Canada expresspharma
June 04, 2021
Similar to the US profit share arrangement, Ocugen will retain 45 per cent of the profits from sales of COVAXIN in Canada.
Bharat Biotech and Gujarat Covid Vaccine Consortium sign MoU for drug substance of COVAXIN expresspharma
May 31, 2021
An MOU has been signed between Bharat Biotech International and Gujarat Covid Vaccine Consortium (GCVC) towards contract manufacturing for the Drug Substance for COVAXIN.
Significant adverse effect unlikely with doses of different COVID-19 vaccines, but further scrutiny required: Govt expresspharma
May 31, 2021
Any significant adverse effect is unlikely if the second dose of a different COVID-19 vaccine is administered, but reaching a firm opinion on this will need more scrutiny and understanding, the Centre said.
120 days to make, test and release each Covaxin batch: Bharat Biotech expresspharma
May 31, 2021
Production scale-up of vaccines is a step-by-step process, involving several regulatory SOPs of GMP. There is a four-month lag time for Covaxin to translate into actual vaccination, a statement by the company said.
Bharat Biotech may begin paediatric trials of COVAXIN in June expresspharma
May 26, 2021
Bharath Biotech has received permission to carry out paediatric trials of the vaccine and it may commence trials from June 1.
Paediatric trials of Covaxin are likely to start from June 1: Dr Raches Ella expresspharma
May 24, 2021
Bharat Biotech is ramping up its manufacturing capacity to 700 million doses which are likely to be achieved by the end of this year, said Dr Raches Ella.
Bharat Biotech ramps up COVAXIN production volumes by additional 200 million expresspharma
May 21, 2021
Bharat Biotech announced the ramp-up of additional manufacturing capacities for COVAXIN at Chiron Behring Vaccines, Ankleshwar Gujarat, a wholly-owned subsidiary of Bharat Biotech.
Bharat Biotech’s Karnataka facility will be able to make 4-5 cr Covaxin doses a month by Aug end: Minister expresspharma
May 19, 2021
He also said that Bharat Biotech's facility in Hyderabad can produce one crore doses of COVID vaccine a month.

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 13 Next page